Matthew Raymond
马修·雷蒙德
MD
Department of Cancer Medicine癌症医学部
👥Biography 个人简介
Matthew Raymond is an oncologist at Gustave Roussy with expertise in neuroendocrine tumors (NETs) across multiple primary sites. He has contributed to clinical development of somatostatin analogs (octreotide, lanreotide), everolimus, sunitinib, and PRRT (lutetium DOTATATE) in pancreatic and non-pancreatic NETs. Raymond has contributed to RADIANT series trials of everolimus in NETs and has been involved in European NET network (ENETS) guideline development. His research spans tumor biology, functional NET evaluation, and quality of life outcomes in carcinoid syndrome management.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Everolimus in Pancreatic NETs
Contributed to RADIANT-3 and related trials establishing everolimus as standard second-line therapy for advanced pancreatic neuroendocrine tumors, contributing to FDA and EMA approvals.
PRRT Development in Advanced NETs
Contributed to clinical development and European implementation of PRRT with lutetium-177 DOTATATE for somatostatin receptor-positive NETs, advancing evidence for this targeted radionuclide therapy.
Representative Works 代表性著作
Everolimus for Advanced Pancreatic Neuroendocrine Tumors (RADIANT-3)
New England Journal of Medicine (2011)
Phase III everolimus trial in pancreatic NETs.
177Lu-DOTATATE for Midgut Neuroendocrine Tumors (NETTER-1)
New England Journal of Medicine (2017)
Phase III PRRT trial demonstrating superiority in midgut NETs.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Hope S. Rugo
University of California, San Francisco (UCSF)
Maryam B. Lustberg
Yale School of Medicine / Yale Cancer Center
Sara M. Tolaney
Dana-Farber Cancer Institute / Harvard Medical School
Carlos H. Barrios
PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil
关注 马修·雷蒙德 的研究动态
Follow Matthew Raymond's research updates
留下邮箱，当我们发布与 Matthew Raymond（Gustave Roussy Cancer Campus）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment